1. Inici
  2. Publicacions
  3. Impact of adenomyosis on IVF outcomes in women undergoing donor oocyte transfers: a prospective observational study.

Impact of adenomyosis on IVF outcomes in women undergoing donor oocyte transfers: a prospective observational study.

Data de publicació: Data Ahead of Print:

Autors de IIS La Fe

Autors aliens a IIS La Fe

  • Cosentino, Martina
  • Loiudice, Luisa
  • Martire, Francesco Giuseppe
  • Exacoustos, Caterina

Grups d'Investigació

Abstract

OBJECTIVE: To prospectively examine the association between adenomyosis type, location, and severity with reproductive outcomes in patients undergoing single embryo transfer (SET) with embryos derived from donor oocytes. DESIGN: A prospective observational cohort study. SETTING: University-affiliated in-vitro fertilization center. PATIENT(S): Infertile patients with (n=114) and without (n=114) adenomyosis who received their first donor oocyte transfer between January 2019 and January 2023 were included in the study. INTERVENTION(S): Adenomyosis was confirmed with the presence of at least one direct feature visualized by 2D/3D transvaginal ultrasound, and classified according to type (diffuse, focal), localization (inner/outer myometrium and/or the junctional zone) and uterine extension (mild, moderate, severe). Following an artificial or natural endometrial preparation cycle, patients underwent SET in the blastocyst stage. MAIN OUTCOME MEASURE(S): The primary outcome was the implantation rate. The secondary outcomes were clinical pregnancy, live birth, and miscarriage rate following SET. RESULT: (s): The presence of adenomyosis did not significantly affect the implantation, clinical pregnancy, or live birth rates. However, women with adenomyosis had a significantly higher miscarriage rate compared to those without adenomyosis (20.2% vs. 9.6 %, respectively; p=0.04). The multivariate analysis assessed possible risk factors for each clinical outcome considered in the study and showed that adenomyosis affected the risk of miscarriage. Specifically, TVS-detection of adenomyosis in the junctional zone was associated with over three-fold higher odds of miscarriage (RR 3.28, 95% CI 1.38-7.78; p=0.004). Conversely, adenomyosis features detected exclusively in the outer myometrium were associated with a higher ongoing pregnancy (RR 0.30, 95% CI 0.13-0.72; p=0.004). Diffuse adenomyosis in the JZ and severe adenomyosis raised the odds of miscarriage four-fold (RR 2.29, 95% CI 1.22-4.30; p=0.015; and RR 2.20, 95% CI 1.19-4.04; p=0.005). CONCLUSION: (s): This study demonstrated that while adenomyosis did not significantly reduce the odds of implantation, the direct signs of adenomyosis in the junctional zone and disease severity are significant risk factors for miscarriage in patients receiving donor oocyte transfers. This study highlights the importance of thorough ultrasound examination and detailed adenomyosis classification in the assessment and management of infertile patients.

Copyright © 2023. Published by Elsevier Inc.

Dades de la publicació

ISSN/ISSNe:
0015-0282, 1556-5653

FERTILITY AND STERILITY  ELSEVIER SCIENCE INC

Tipus:
Article
Pàgines:
480-488
PubMed:
38043844
Factor d'Impacte:
1,895 SCImago ℠
Quartil:
Q1 SCImago ℠

Cites Rebudes en Web of Science: 1

Documents

  • No hi ha documents

Mètriques

Filiacions

Filiacions no disponibles

Keywords

  • adenomyosis; donor oocytes; implantation; miscarriage; single embryo transfer; transvaginal ultrasound

Campos d'Estudi

Projectes associats

ESTUDIO DE LA ENFERMEDAD METASTASICA EN EL TEJIDO OVARICO CRIOPRESERVADO DE MUJERES CON CANCER DE MAMA

Investigador Principal: ANTONIO PELLICER MARTÍNEZ

PI08/90483 . INSTITUTO DE SALUD CARLOS III . 2009

CONTRATO POSTDOCTORAL DE INVESTIGACION SARA BORRELL

CD11/00292 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2012

CONTRATO POSTDOCTORAL DE INVESTIGACION SARA BORELL

CD12/00568 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2013

CONTRATO POST FSE (RIO HORTEGA)

CM13/00191 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2014

CONTRATO POSTDOCTORAL DE INVESTIGACION SARA BORRELL

Investigador Principal: ANTONIO PELLICER MARTÍNEZ

CD15/00058 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2016

TRAMIENTO COMBINADO DE VITAMINA D CON AGNRH SOBRE EL CRECIMIENTO DE LOS MIOMAS UTERINOS

Investigador Principal: ANTONIO PELLICER MARTÍNEZ

PI15/00312 . INSTITUTO DE SALUD CARLOS III . 2016

Alternativas para la Preservacion de la fertilidad en pacientes con leucemia aguda. Maduracion in vivo mediante xenotransplante.

Investigador Principal: ANTONIO PELLICER MARTÍNEZ

GRISOLIAP/2018/029 . CONSELLERIA DE EDUCACION . 2018

Contrato PFIS: Predoctorales de formación en investigación en salud. Elena Juarez

Investigador Principal: ANTONIO PELLICER MARTÍNEZ

FI19/00110 . INSTITUTO DE SALUD CARLOS III . 2020

ESTUDIO CLÍNICO PILOTO PARA EVALUAR EL EFECTO DE LA VITAMINA D SOBRE EL TAMAÑO DE LOS MIOMAS EN MUJERES CON DEFICIENCIA DE VITAMINA D.

Investigador Principal: ANTONIO PELLICER MARTÍNEZ

IIS-COL-2018-01 . 2019

ESTUDIO ALEATORIZADO, DOBLE CIEGO, CONTROLADO CON PLACEBO, PARA EVALUAR SEGURIDAD Y EFICACIA DE ELAGOLIX EN PARTICIPANTES CON DOLOR MODERADO O SEVERO ASOCIADO A ENDOMETRIOSIS.

Investigador Principal: VICENTE PAYÁ AMATE

M12-671

IMPACTO DE LA INFECCIÓN POR SARS-COV-2 (COVID-19) EN EL ENDOMETRIO HUMANO: EVALUACIÓN IN VITRO DE LOS EFECTOS DE HIDROXICLOROQUINA (HCQ) UTILIZANDO ORGANOIDES ENDOMETRIALES HUMANOS.

Investigador Principal: IRENE CERVELLÓ ALCARAZ

2020-268-1_CRC FERRING COVID_CERVELLO . FERRING PHARMACEUTICALS A/S . 2020

Efecto de la Vitamina D y los Disruptores Endocrinos sobre la Longitud Telomérica en Células del Cúmulo y los Resultados Reproductivos.

Investigador Principal: ANTONIO PELLICER MARTÍNEZ

PI21/00310 . INSTITUTO DE SALUD CARLOS III . 2022

PREPARACION DE FOLICULOS ANTRALES, PREVIA A FECUNDACION IN VITRO TIPO ICSI, EN PACIENTES CON BAJA RESPUESTA OVARICA. ENSAYO CLINICO PROSPECTIVO ALEATORIZADO CONTROLADO.

Investigador Principal: CÉSAR DÍAZ GARCÍA

FOLLPRIM

IMPACT OF SERUM PROGESTERONE CONCENTRATION ON THE DAY OF EMBRYO TRANSFER IN MODIFIED NATURAL CYCLES AND STIMULATED CYCLES ON ONGOING PREGNANCY RATE.

Investigador Principal: MARÍA ELENA LABARTA DEMUR

IVI-PRO-2019-02

PLASMA RICO EN PLAQUETAS PROCEDENTE DE CORDÓN UMBILICAL PARA EL TRATAMIENTO DE PATOLOGÍAS ENDOMETRIALES (ENDOMETRIO FINO/ SÍNDROME DE ASHERMAN/ ATROFIA ENDOMETRIAL): UN ESTUDIO PILOTO.

Investigador Principal: MÓNICA ROMEU VILLARROYA

2001-FIVI-002-IC . 2021

Estudio de los mecanismos moleculares relacionados con la resistencia a insulina y resistencia a progesterona que influyen en la receptividad endometrial en pacientes con adenomiosis.

Investigador Principal: ANTONIO PELLICER MARTÍNEZ

FPU21/01178 . MINISTERIO DE UNIVERSIDADES . 2022

Compartir la publicació